EDGAR 10-K Filing

Company CIK: 1458023
Filing Year: 2022
Filename: 1458023_10-K_2022_0001829126-22-008249.json

---

ITEM 1. BUSINESS
Item
1. Business.
Recent
Developments
Change
in Fiscal Year-End
On
January 29, 2021, the Board of Directors of Flowerkist Skin Care and Cosmetics, Inc., (the “Company”) approved the
change in the Company’s fiscal year end from July 31 to December 31.
Coronavirus
(COVID-19)
On
March 11, 2020, the World Health Organization declared the COVID-19 outbreak to be a global pandemic which continues to spread
throughout the U.S. and the globe. In addition to the devastating effects on human life, the pandemic is having a negative ripple
effect on the global economy, leading to disruptions and volatility in the global financial markets. Most U.S. states and many
countries have issued policies intended to stop or slow the further spread of the disease such as issuing temporary Executive
Orders that, among other stipulations, effectively prohibit in-person work activities for most industries and businesses, having
the effect of suspending or severely curtailing operations. COVID-19 and the U. S’s response to the pandemic are significantly
affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may have, and,
as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. The extent of the ultimate impact
of the pandemic on the Company’s operational and financial performance will depend on various developments, including the
duration and spread of the outbreak, which cannot be reasonably predicted at this time. Accordingly, while management reasonably
expects the COVID-19 outbreak to negatively impact the Company, the related consequences and duration are highly uncertain and
cannot be predicted at this time.
History
and Overview
We
were formerly a Nevada corporation based out of Orlando, Florida. We intended to participate in cutting edge development and import
and sell state of the art 3D printers, scanners, and ancillary equipment. Our mission was to provide individual and corporate
customers with the most advanced and reliable cutting edge 3D printing technology in the most cost effective packages available
in the marketplace at whatever level is appropriate for their needs. We want our business to be the “go to” vendor
of 3D printers for individuals and businesses. Our focus was on the development of powderless metal and medical printers and printing
technology.
The
3D printing industry is in its very early stages but is already getting more press and generating more excitement than almost
any other technological development of recent years. It is not often that a new idea is constantly described as moving the goalposts
for the way we actually live our lives. Amidst all the press and the hype, the reality of what the technology is capable of and
the speed of its improvement is breathtaking.
We
were committed to supplying the best plastic, medical, culinary, and powderless metal 3D printers in the industry, and we are
supplied by one of the largest and most experienced 3D printing research, development, and manufacturing entities in the world.
3D MakerJet’s research and development partner and manufacturer, ZBOT / Guangzhou DNSPOWER Design Co. LTD, was founded in
2000, and is a leader in the 3D printing industry. A cutting-edge developer in the manufacturing sector, ZBOT won the coveted
CDA National Design Award for its ZBOT 3D Printer, which is the platform of the 3D MakerJet printer line, making their 3D printer
the only CDA winner at the Civilian level, reflecting the product’s superior quality, as well as the manufacturer’s
comprehensive strength, commitment, and capabilities.
We
have been dormant since January 2016.
On
July 14, 2020, as a result of a custodianship in Clark County, Nevada, Case Number: A-20-816260-B, Custodian Ventures LLC (“Custodian”)
was appointed custodian of the Company. David Lazar is the managing member of Custodian.
On
July 16, 2020, Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief Financial
Officer, Chief Executive Officer and Chairman of the Board of Directors.
On
January 29, 2021, the Board of Directors of Company approved the change in the Company’s fiscal year end from July 31 to
December 31. As required, the Company will file a transition report on Form 10-K covering the transition period with the Securities
and Exchange Commission.
On
March 22, 2021, as a result of a private transactions, 10,000,000 shares of Series A Preferred Stock, $0.001 par value per share
were transferred from Custodian Ventures, LLC to Flowerkist Inc. (the “Purchaser”). As a result, the Purchaser became
an approximately 70% holder of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted
basis of the Company and became the controlling shareholder. The consideration paid for the Shares was $250,000. The source of
the cash consideration for the Shares was personal funds of the Purchaser. In connection with the transaction, David Lazar released
the Company from all debts owed to him.
On
March 22, 2021, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an
officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and
a Director. At the effective date of the transfer, Barry Clark consented to act as the new President, CEO, CFO, Treasurer, Secretary
and Chairman of the Board of Directors of the Company.
Barry
Clark, 62, is the co-founder of Flowerkist, Inc., along with Stephanie Clark and the Chairman of the Board of Directors, which
was founded in 2017. He also acts as a business mentor at CanopySD, a seed-stage mentorship-driven accelerator program for the
legal cannabis industry in Southern California. Mr. Clark was the founder and managing director of Sussex Partners Investor Relations
and Regal Barrington from 2004 through 2014.
On
August 17, 2021, 3D Makerjet, Inc., amended its Articles of Incorporation change its name to Flowerkist Skin Care and Cosmetics,
Inc. The change was made in anticipation of entering into a new line of business operations.
Also
on August 17, 2021, the Company amended its articles of incorporation to reverse split its common stock at a rate of 1 for
1,000.
On
September 14, 2021, Stephanie Parker was appointed as a director and as President and Secretary of the Company. Also, on September
14, 2021, Ms. Parker accepted such an appointment. Ms. Parker is not independent using the definition of independence under NASDAQ
Listing Rule 5605(a)(2) and the standards established by the Securities and Exchange Commission. Ms. Parker was formerly married
to Barry Clark.
Employees
As
of the date of this Current Report, the Company has no full-time employees.
Reports
to Security Holders
We
intend to furnish our shareholders’ annual reports containing financial statements audited by our independent registered
public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first
three quarters of each year. We file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K
with the Securities and Exchange Commission in order to meet our timely and continuous disclosure requirements. We may also file
additional documents with the Commission if they become necessary in the course of our company’s operations.
The
public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE,
Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information
regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.

---

ITEM 1A. RISK FACTORS
Item
1A. Risk Factors.
YOU
SHOULD CAREFULLY CONSIDER THE RISKS AND UNCERTAINTIES DESCRIBED BELOW AND THE OTHER INFORMATION CONTAINED OR INCORPORATED BY REFERENCE
IN THIS TRANSITION REPORT ON FORM 10-K BEFORE DECIDING WHETHER TO INVEST IN THE COMPANY’S COMMON STOCK. ADDITIONAL RISKS
AND UNCERTAINTIES NOT PRESENTLY KNOWN TO THE COMPANY OR THAT THE COMPANY CURRENTLY DEEMS IMMATERIAL MAY ALSO IMPAIR THE COMPANY’S
BUSINESS OPERATIONS. IF ANY OF THE FOLLOWING RISKS ACTUALLY OCCUR, THE COMPANY’S BUSINESS, FINANCIAL CONDITION OR OPERATING
RESULTS COULD BE MATERIALLY ADVERSELY AFFECTED. IN SUCH CASE, THE TRADING PRICE OR THE COMPANY’S COMMON STOCK COULD DECLINE
AND YOU MAY LOSE PART OR ALL OF YOUR INVESTMENT. THIS TRANSITION REPORT ON FORM 10-K ALSO CONTAINS FORWARD-LOOKING STATEMENTS
THAT INVOLVE RISKS AND UNCERTAINTIES. PLEASE SEE “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS”.
Risks
Related to our Company
We
have a history of operating losses and our auditors have indicated that there is substantial doubt about our ability to continue
as a going concern.
The
Company’s financial statements have been presented on the basis that it is a going concern, which contemplates the realization
of assets and the satisfaction of liabilities in the normal course of business. On December 31, 2021, the Company had an accumulated
deficit of $3,378,176 and working capital of $-0-. The financial statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern. The Company’s continuation as a going concern is solely dependent
upon the Company’s ability to raise financing from third parties. There is no assurance that the Company will be successful
in doing so. For further discussion about our ability to continue as a going concern and our plan for future liquidity, see “Management’s
Discussion and Analysis of Financial Condition and Results of Operations.”
Because
we are a “shell company” the holders of our restricted securities will not be able to sell their securities in reliance
on Rule 144 and we cannot file registration statements under Section 5 of the Securities Act using a Form S-8, until we cease
being a “shell company”.
We
are a “shell company” as that term is defined by the applicable federal securities laws. Applicable provisions of
Rule 144 specify that during that time that we are a “shell company” and for a period of one year thereafter, holders
of our restricted securities cannot sell those securities in reliance on Rule 144. This restriction may have potential adverse
effects on future efforts to form additional capital through unregistered offerings. Another implication of us being a shell company
is that we cannot file registration statements under Section 5 of the Securities Act using a Form S-8, a short form of registration
to register securities issued to employees and consultants under an employee benefit plan. As result, one year after we cease
being a shell company, assuming we are “current” in our reporting requirements with the Securities and Exchange Commission
and have filed current “Form 10 information” with the SEC reflecting our status as an entity that is no longer a shell
company for a period of not less than 12 months, holders of our restricted securities may then sell those securities in reliance
on Rule 144 (provided, however, those holders satisfy all of the applicable requirements of that rule).
We
may fail to successfully execute our business plan.
Our
shareholders may lose their entire investment if we fail to execute our business plan. Our prospects must be considered in light
of the following risks and uncertainties, including but not limited to, competition, the ability to retain experienced personnel
and general economic conditions. We cannot guarantee that we will be successful in executing our business plan. If we fail to
successfully execute our business plan, our shareholders may lose their entire investment.
The
Company may suffer from lack of availability of additional funds.
We
expect to have ongoing needs for working capital in order to fund operations and to continue to expand our operations. To that
end, we will be required to raise additional funds through equity or debt financing. However, there can be no assurance that we
will be successful in securing additional capital on favorable terms, if at all. If we are successful, whether the terms are favorable
or unfavorable, there is a potential that we will fail to comply with the terms of such financing, which could result in severe
liability for our Company. If we are unsuccessful, we may need to (a) initiate cost reductions; (b) forego business development
opportunities; (c) seek extensions of time to fund liabilities, or (d) seek protection from creditors. In addition, any future
sale of our equity securities would dilute the ownership and control of your shares and could be at prices substantially below
prices at which our shares currently trade. Our inability to raise capital could require us to significantly curtail or terminate
our operations altogether. We may seek to increase our cash reserves through the sale of additional equity or debt securities.
The sale of convertible debt securities or additional equity securities could result in additional and potentially substantial
dilution to our shareholders. The incurrence of indebtedness would result in increased debt service obligations and could result
in operating and financing covenants that would restrict our operations and liquidity. In addition, our ability to obtain additional
capital on acceptable terms is subject to a variety of uncertainties.
In
addition, if we are unable to generate adequate cash from operations, and if we are unable to find sources of funding, it may
be necessary for us to sell all or a portion of our assets, enter into a business combination, or reduce or eliminate operations.
These possibilities, to the extent available, may be on terms that result in significant dilution to our shareholders or that
result in our shareholders losing all of their investment in our Company.
Our
acquisition strategy creates risks for our business.
We
expect that we will pursue acquisitions of other businesses, assets, or technologies to grow our business. We may fail to identify
attractive acquisition candidates, or we may be unable to reach acceptable terms for future acquisitions. We might not be able
to raise enough cash to compete for attractive acquisition targets. If we are unable to complete acquisitions in the future, our
ability to grow our business will be impaired.
We
may pay for acquisitions by issuing additional shares of our common stock, which would dilute our stockholders, or by issuing
debt, which could include terms that restrict our ability to operate our business or pursue other opportunities and subject us
to meaningful debt service obligations. We may also use significant amounts of cash to complete acquisitions. To the extent that
we complete acquisitions in the future, we likely will incur future depreciation and amortization expenses associated with the
acquired assets. We may also record significant amounts of intangible assets, including goodwill, which could become impaired
in the future. Acquisitions involve numerous other risks, including:
● difficulties
integrating the operations, technologies, services, and personnel of the acquired companies;
● challenges
maintaining our internal standards, controls, procedures, and policies;
● diversion
of management’s attention from other business concerns;
● over-valuation
by us of acquired companies;
● litigation
resulting from activities of the acquired company, including claims from terminated employees, customers, former stockholders
and other third parties;
● insufficient
revenues to offset increased expenses associated with the acquisitions and unanticipated liabilities of the acquired companies;
● insufficient
indemnification or security from the selling parties for legal liabilities that we may assume in connection with our acquisitions;
● entering
markets in which we have no prior experience and may not succeed;
● risks
associated with foreign acquisitions, such as communication and integration problems resulting from geographic dispersion
and language and cultural differences, compliance with foreign laws and regulations and general economic or political conditions
in other countries or regions;
● potential
loss of key employees of the acquired companies; and
● impairment
of relationships with clients and employees of the acquired companies or our clients and employees as a result of the integration
of acquired operations and new management personnel.
The
recent outbreak of the coronavirus may cause an overall decline in the economy as a whole and may materially harm our Company.
If
the recent outbreak of the COVID-19 coronavirus continues to grow, the effects of such a widespread infectious disease and epidemic
may cause an overall decline in the economy as a whole. The actual effects of the spread of coronavirus are difficult to assess
at this time as the actual effects will depend on many factors beyond the control and knowledge of the Company. However, the spread
of the coronavirus, if it continues may cause an overall decline in the economy as a whole and therefore may materially harm our
Company. Accordingly, while management reasonably expects the COVID-19 outbreak to negatively impact the Company, the related
consequences and duration are highly uncertain and cannot be predicted at this time.
We
may be unable to scale our operations successfully.
Our
growth strategy will place significant demands on our management and financial, administrative, and other resources. Operating
results will depend substantially on the ability of our officers and key employees to manage changing business conditions and
to implement and improve our financial, administrative, and other resources. If the Company is unable to respond to and manage
changing business conditions, or the scale of its operations, then the quality of its services, its ability to retain key personnel,
and its business could be harmed.
The
Company may suffer from a lack of liquidity.
By
incurring indebtedness, the Company subjects itself to increased debt service obligations which could result in operating and
financing covenants that would restrict our operations and liquidity. This would impair our ability to hire the necessary senior
and support personnel required for our business, as well as carry out its acquisition strategy and other business objectives.
Economic
conditions or changing consumer preferences could adversely impact our business.
A
downturn in economic conditions in one or more of the Company’s future markets could have a material adverse effect on our
results of operations, financial condition, business, and prospects. The existing federal deficit, as well as deficit spending
by the government as the result of adverse developments in the economy or other reasons, can lead to continuing pressure to reduce
government expenditures for other purposes. Such actions in turn may adversely affect our results of operations. Although we attempt
to stay informed of government and customer trends, any sustained failure to identify and respond to trends could have a material
adverse effect on our results of operations, financial condition, business, and prospects.
The
requirements of remaining a public company may strain our resources and distract our management, which could make it difficult
to manage our business.
We
are required to comply with various regulatory and reporting requirements, including those required by the SEC. Complying with
these reporting and other regulatory requirements are time-consuming and expensive and could have a negative effect on our business,
results of operations and financial condition.
We
are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley
Act”) and if we fail to continue to comply, our business could be harmed, and the price of our securities could decline.
Rules
adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act require an annual assessment of internal control over financial
reporting, and for certain issuers an attestation of this assessment by the issuer’s independent registered public accounting
firm. The standards that must be met for management to assess the internal control over financial reporting as effective are evolving
and complex, and require significant documentation, testing, and possible remediation to meet the detailed standards. We expect
to incur significant expenses and to devote resources to Section 404 compliance on an ongoing basis. It is difficult for us to
predict how long it will take or costly it will be to complete the assessment of the effectiveness of our internal control over
financial reporting for each year and to remediate any deficiencies in our internal control over financial reporting. As a result,
we may not be able to complete the assessment and remediation process on a timely basis. In the event that we determine that our
internal control over financial reporting is not effective as defined under Section 404, we cannot predict how regulators will
react or how the market prices of our securities will be affected; however, we believe that there is a risk that investor confidence
and the market value of our securities may be negatively affected.
Risks
Related to Our Common Stock
Our
Common Stock Currently Trades on the Pink Tier of OTC Markets.
Our
Common Stock currently trades on the Pink Tier of OTC Market Group LLC’s Marketplace under the symbol “FKST”
and is labeled as “Pink Current Information” at this time. On August 20, 2021, FINRA declared the Name Change effective.
The OTC Market is a network of security dealers who buy and sell stock. The dealers are connected by a computer network that provides
information on current “bids” and “asks,” as well as volume information. The trading of securities on
the OTC Pink is often sporadic and investors may have difficulty buying and selling our shares or obtaining market quotations
for them, which may have a negative effect on the market price of our common stock.
Our
common stock is subject to the application of the “penny stock” rules which could adversely affect the market price
of our common stock and increase transaction costs to sell those shares.
The
SEC has adopted rule 3a51-1 which establishes the definition of a “penny stock,” for the purposes relevant to us,
as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share,
subject to certain exceptions. For any transaction involving a penny stock, unless exempt, Rule 15g-9 requires:
● that
a broker or dealer approve a person’s account for transactions in penny stocks, and
● the
broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity
of the penny stock to be purchased.
In
order to approve a person’s account for transactions in penny stocks, the broker or dealer must:
● obtain
financial information and investment experience objectives of the person, and
● make
a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.
The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form:
● sets
forth the basis on which the broker or dealer made the suitability determination and
● that
the broker or dealer received a signed, written agreement from the investor prior to the transaction.
Generally,
Brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make
it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.
The
market price for our common stock is particularly volatile which could lead to wide fluctuations in our share price. You may be
unable to sell your common stock shares at or above your purchase price, or at all, which may result in substantial losses to
you.
The
market for our common stock is characterized by significant price volatility when compared to seasoned issuers, and we expect
that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. As a consequence of this
enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of negative
news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would
be the case with the stock of a seasoned issuer. Many of these factors are beyond our control and may decrease the market price
of our common stock regardless of our operating performance. We cannot make any predictions or projections as to what the prevailing
market price for our common stock shares will be at any time, or as to what effect the sale of shares or the availability of common
stock shares for sale at any time will have on the prevailing market price.
Because
we will likely issue additional shares of our common stock, investment in the Company could be subject to substantial dilution.
Investors’
interests in the Company will be diluted and investors may suffer dilution in their net book value per share when we issue additional
shares. We are authorized to issue 300,000,000 shares of common stock. We anticipate that all or at least some or potentially
all of our future funding, if any, will be in the form of equity financing from the sale of our common stock. If we do sell or
issue more common stock, any investors’ investment in the Company will be diluted. Dilution is the difference between what
you pay for your stock and the net tangible book value per share immediately after the additional shares are sold by us. If dilution
occurs, any investment in the Company’s common stock could seriously decline in value.
FINRA
sales practice requirements may also limit a stockholder’s ability to buy and sell our stock.
In
addition to the “penny stock” rules described above, FINRA has adopted FINRA Rule 2111 that requires a broker-dealer
to have reasonable grounds for believing that an investment is suitable for a customer before recommending the investment. Prior
to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts
to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under
interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not
be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their
customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market
for our shares.
We
do not intend to pay dividends for the foreseeable future.
We
have never declared or paid any cash dividends on our stock and do not intend to pay any cash dividends in the foreseeable future.
We anticipate that we will retain all of our future earnings for use in the development of our business and for general corporate
purposes. Any determination to pay dividends in the future will be at the discretion of our Board of Directors.
If
we are unable to comply with the financial reporting requirements mandated by the SEC’s regulations, investors may lose
confidence in our financial reporting and the price of our common stock, if a market ever does develop for it, could decline.
If
we fail to maintain effective internal controls over financial reporting, our ability to produce timely, accurate and reliable
periodic financial statements could be impaired. If we do not maintain adequate internal control over financial reporting, investors
could lose confidence in the accuracy of our periodic reports filed under the Exchange Act. Additionally, our ability to obtain
additional financing could be impaired or a lack of investor confidence in the reliability and accuracy of our public reporting
could cause our stock price to decline.

---

ITEM 1B. UNRESOLVED STAFF COMMENTS
Item
1B. Unresolved Staff Comments.
Not
applicable.

---

ITEM 2. PROPERTIES
Item
2. Properties.
The
Company has no properties.

---

ITEM 3. LEGAL PROCEEDINGS
Item
3. Legal Proceedings
We
are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers,
directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse
to us.

---

ITEM 4. MINE SAFETY DISCLOSURE
Item
4. Mine Safety Disclosures.
Not
applicable.
Part
II

---

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
Market
Information
Our
Common Stock is quoted on the over the counter “pink sheets” under the trading symbol “FKST”
Transfer
of our common stock may also be restricted under the securities or blue sky laws of certain states and foreign jurisdictions.
Consequently, investors may not be able to liquidate their investments and should be prepared to hold the common stock for an
indefinite period of time.
The
following table sets forth the high and low bid quotations for our Common Stock as reported on the pink sheets for the periods
indicated.
Fiscal
$
High
$
Low
First
Quarter -March, 2021
105.00
5.20
Second
Quarter -June, 2021
49.00
23.00
Third
Quarter-September 2021
59.00
4.30
Fourth
Quarter-December, 2021
10.00
3.76
Fiscal
$
High
$
Low
First
Quarter-March 2020
4.40
1.60
Second
Quarter-June 2020
8.00
2.00
Third
Quarter-September 2020
14.90
7.00
Fourth
Quarter-December 2020
14.00
5.20
As of April 14, 2022 the closing price of our Common Stock was $4.23 per share.
Holders
of Our Common Stock
As
of March 31, 2022 we had 130,200 shares of our common stock issued and outstanding, held by twenty-seven (27) shareholders of
record, with others holding shares in street name.
Dividends
There
are no restrictions in our articles of incorporation or bylaws that prevent us from declaring dividends. The Nevada Revised Statutes,
however, do prohibit us from declaring dividends where after giving effect to the distribution of the dividend:
1. We would not be
able to pay our debts as they become due in the usual course of business, or;
2. Our total assets
would be less than the sum of our total liabilities plus the amount that would be needed to satisfy the rights of shareholders
who have preferential rights superior to those receiving the distribution.
We
have not declared any dividends and we do not plan to declare any dividends in the foreseeable future.
Securities
Authorized for Issuance under Equity Compensation Plans
We
do not have any equity compensation plans.

---

ITEM 6. SELECTED FINANCIAL DATA
Item
6. Selected Financial Data.
Not
required for smaller reporting companies.

---

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS
Item
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking
Statements
Certain
statements, other than purely historical information, including estimates, projections, statements relating to our business plans,
objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the
words “believes,” “project,” “expects,” “anticipates,” “estimates,”
“intends,” “strategy,” “plan,” “may,” “will,” “would,”
“will be,” “will continue,” “will likely result,” and similar expressions. We intend such
forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995 and are including this statement for purposes of complying with those safe-harbor provisions.
Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which
may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual
effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations
and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory
changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties
should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.
We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information,
future events or otherwise. Further information concerning our business, including additional factors that could materially affect
our financial results, is included herein and in our other filings with the SEC.
Change
in Fiscal Year-End
On
January 29, 2021, the Board of Directors of Flowerkist Skin Care and Cosmetics, Inc. (the “Company”) approved the
change in our fiscal year end from July 31 to December 31.
Plan
of Operation
The
Company’s current business objective is to seek a business combination with an operating company. We intend to use the Company’s
limited personnel and financial resources in connection with such activities. The Company will utilize its capital stock, debt
or a combination of capital stock and debt, in effecting a business combination. It may be expected that entering into a business
combination will involve the issuance of restricted shares of capital stock. The issuance of additional shares of our capital
stock:
● may significantly
reduce the equity interest of our stockholders;
● will likely cause
a change in control if a substantial number of our shares of capital stock are issued, and most likely will also result in
the resignation or removal of our present officer and director; and
● may adversely affect
the prevailing market price for our common stock.
Similarly,
if we issued debt securities, it could result in:
● default and foreclosure
on our assets if our operating revenues after a business combination were insufficient to pay our debt obligations;
● acceleration of
our obligations to repay the indebtedness even if we have made all principal and interest payments when due if the debt security
contained covenants that required the maintenance of certain financial ratios or reserves and any such covenants were breached
without a waiver or renegotiations of such covenants;
● our immediate payment
of all principal and accrued interest, if any, if the debt security was payable on demand; and
● our inability to
obtain additional financing, if necessary, if the debt security contained covenants restricting our ability to obtain additional
financing while such security was outstanding.
Going
Concern
We
were formed in January 2009. We have negative working capital, no cash on hand, have an accumulated deficit and have no sources
of financing. While we are attempting to expand operations and produce revenues, our cash position may not be significant enough
to support our daily operations. Management will seek funds from outside business contacts as needed. There can be no assurances
to that our business plan will succeed.
Our
ability to continue as a going concern is dependent upon our ability to further implement our business plan and generate revenues.
The financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.
Critical
Accounting Policies
In
December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management
Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the
portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective, or
complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.
We do not believe that any accounting policies currently fit this definition.
Recently
Issued Accounting Pronouncements
We
do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operations,
financial position, or cash flow.
Off
Balance Sheet Arrangements
As
of December 31, 2021, there were no off-balance sheet arrangements.

---

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Item
7A. Quantitative and Qualitative Disclosures About Market Risk
A
smaller reporting company is not required to provide the information required by this Item.

---

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Item
8. Financial Statements and Supplementary Data
Index
to Financial Statements Required by Article 8 of Regulation S-X:
Financial
Statements:
Report
of Independent Registered Public Accounting Firm
Consolidated
Balance Sheets as of December 31, 2021 and December 31, 2020
Consolidated
Statements of Operations for the Years ended December 31, 2021 and 2020
Consolidated
Statements of Changes in Shareholders Equity for the Years ended December 31, 2021 and December 31, 2020
Consolidated
Statements of Cash flows for the Years ended December 31, 2021 and 2020
Notes
to Consolidated Financial Statements
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the board of directors of Flowerkist Skin Care and Cosmetics, Inc.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Flowerkist Skin Care and Cosmetics, Inc. as of December 31, 2021 and 2020, the related statements of operations, stockholders’ equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States.
Substantial Doubt about the Company’s Ability to Continue as a Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Critical Audit Matter
Critical audit matters are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.
We determined that there are no critical audit matters.
/S BF Borgers CPA PC
We have served as the Company’s auditor since 2020
Lakewood, CO
April 15, 2022
Flowerkist
Skin Care and Cosmetics, Inc.
Balance
Sheets
December 31,
December 31,
ASSETS
Total
assets
$ -
$ -
LIABILITIES
AND STOCKHOLDERS' EQUITY
Current
liabilities:
Notes
payable- related parties
$ 1,972
$ 5,345
Total
current liabilities
1,972
5,345
Total
Liabilities
1,972
5,345
Commitments
and contingencies
-
-
Stockholders'
Deficit:
Preferred
stock: $0.0001 par value 10,000,000 shares authorized, 10,000,000 and 10,000,000 shares issued and outstanding as of December
31, 2021 and December, 31, 2020
1,000
1,000
Common
stock, $0.001 par value, 300,000,000 shares authorized; 130,212 and 130,212 issued and outstanding as of December 31, 2021
and December 31, 2020
Additional
paid-in capital
3,375,074
3,369,729
Accumulated
deficit
(3,378,176 )
(3,376,204 )
Total
stockholders' equity
(1,972 )
(5,345 )
Total
liabilities and equity
$ -
$ -
The
accompanying notes are part of the financial statements.
Flowerkist
Skin Care and Cosmetics, Inc.
Statements
of Operations
Year
Ended
December 31,
Five
months Ended
December 31,
Revenue
$ -
$ -
Cost
of revenue
-
-
Gross
profit
-
-
Operating
expenses:
General
and administrative -related party
1,972
2,459,914
Total
operating expenses
1,972
2,459,914
Loss from operations
(1,972 )
(2,459,914 )
Other
income
Gain
from extinguishment of debt
-
877,920
Total
other income (expense)
-
877,920
Net
loss
$ (1,972 )
$ (1,581,994 )
Basic
and diluted earnings (loss) per common share
$ (0.02 )
$ (12.15 )
Weighted-average
number of common shares outstanding:
Basic
and diluted
130,212
130,212
The
accompanying notes are an integral part of the financial statements.
Flowerkist
Skin Care and Cosmetics, Inc.
Statements
of Changes in Shareholders Equity
Preferred
Stock Series
Common
stock
Paid-in
Accumulated
Stockholders'
Shares
Value
Shares
Value
Capital
Deficit
Equity
Balance,
July 31, 2020 (unaudited)
-
$ -
130,212
$
$ 910,729
$ (1,794,210 )
$ (883,351 )
Net
income (loss)
-
(1,581,994 )
(1,581,994 )
Issuance
of preferred stock to related party
10,000,000
1,000
2,459,000
2,460,000
Balance,
December 31, 2020
10,000,000
$ 1,000
130,212
$
$ 3,369,729
$ (3,376,204 )
$ (5,345 )
Additional
Total
Preferred
Stock Series
Common
stock
Paid-in
Accumulated
Stockholders'
Shares
Value
Shares
Value
Capital
Deficit
Equity
Balance,
December 31, 2020
10,000,000
1,000
130,212
$
$ 3,369,729
$ (3,376,204 )
$ (5,345 )
Net
income (loss)
-
-
-
(1,972 )
(1,972 )
Capital
contribution from former related party
5,345
5,345
Balance,
December 31, 2021
10,000,000
$ 1,000
130,212
$
$ 3,375,074
$ (3,378,176 )
$ (1,972 )
The
accompanying notes are an integral part of the financial statements.
Flowerkist
Skin Care and Cosmetics, Inc.
Statements
of Cash flows
Year
Ended
December 31,
Five
months ended
December 31,
Cash
flows used in operating activities:
Net
loss
$ (1,972 )
$ (1,581,994 )
Adjustments
to reconcile net loss to net cash used in operating activities
Stock
based compensation
-
2,450,000
Changes
in operating assets and liabilities
Accounts
payable and accrued liabilities
-
(232,227 )
Convertible
notes
-
(602,693 )
Notes
payable
-
(43,000 )
Net
cash used in operating activities
(1,972 )
(9,914 )
Cash
flows used in investing activities:
Net
cash provided by (used in) Investing Activities
-
-
Cash
flows from financing activities:
Proceeds
from related party advances
1,972
9,914
Net
cash provided by financing activities
1,972
9,914
Net
increase (decrease) in cash and cash equivalents
-
-
Cash
and cash equivalents at beginning of period
-
-
Cash
and cash equivalents at end of period
$ -
$ -
Supplemental
disclosure of non-cash information:
Forgiveness
of debt by former related party due to a change of control
$ 5,345
$ -
The
accompanying notes are an integral part of the financial statements.
FLOWERKIST
SKIN CARE AND COSMETICS, INC.
NOTES
TO FINANCIAL STATEMENTS
NOTE
1 - ORGANIZATION AND DESCRIPTION OF BUSINESS
Flowerkist
Skin Care And Cosmetics, Inc. f/k/a 3D MakerJet, Inc. (“Flowerkist “or the “Company”), formerly known
as American Business Change Agents, Inc., was incorporated under the laws of the State of Nevada on January 12, 2009. On May 4,
2014, the name of the Company was changed to 3D MakerJet, Inc. The Company had been developing a business plan focused on the
sale of 3D printers, scanners, and ancillary equipment. 3D MakerJet, Inc.
On
May 4, 2014, the name of the Company was changed to 3D MakerJet, Inc. the Company has been dormant since January 2016.
On
July 14, 2020, as a result of a custodianship in Clark County, Nevada, Case Number: A-20-816260-B, Custodian Ventures LLC (“Custodian”)
was appointed custodian of the Company. David Lazar is the managing member of Custodian.
On
July 16, 2020, Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief Financial
Officer, Chief Executive Officer, and Chairman of the Board of Directors.
On
January 29, 2021, the Board of Directors of the Company approved the change in the Company’s fiscal year-end from July 31
to December 31. As required, the Company will file a transition report on Form 10-K covering the transition period with the Securities
and Exchange Commission.
On
March 22, 2021, as a result of a private transaction, 10,000,000 shares of Series A Preferred Stock, $0.001 par value per share
were transferred from Custodian Ventures, LLC to Flowerkist Inc. (the “Purchaser”). As a result, the Purchaser became
an approximately 70% holder of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted
basis of the Company and became the controlling shareholder. The consideration paid for the Shares was $250,000. The source of
the cash consideration for the Shares was corporate funds of the Purchaser. In connection with the transaction, David Lazar released
the Company from all debts owed to him.
On
March 22, 2021, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an
officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and
a Director. At the effective date of the transfer, Barry Clark consented to act as the new President, CEO, CFO, Treasurer, Secretary,
and Chairman of the Board of Directors of the Company.
On
August 17, 2021, 3D Makerjet, Inc., amended its Articles of Incorporation change its name to Flowerkist Skin Care and Cosmetics,
Inc. The change was made in anticipation of entering into a new line of business operations.
Also
on August 17, 2021, the Company amended its articles of incorporation to reverse split its common stock at a rate of 1 for 1,000.
On
September 14, 2021, Stephanie Parker was appointed as a director and as President and Secretary of the Company. Also, on September
14, 2021, Ms. Parker accepted such an appointment. Ms. Parker is not independent using the definition of independence under NASDAQ
Listing Rule 5605(a)(2) and the standards established by the Securities and Exchange Commission. Ms. Parker was formerly married
to Barry Clark.
NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”)
“FASB Accounting Standard Codification™” (the “Codification”) which is the source of authoritative
accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements
in conformity with generally accepted accounting principles (“GAAP”) in the United States.
Going
Concern
The
accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following
the date of these financial statements. As of December 31, 2021 the Company had an accumulated deficit of $3,378,176.
Because
the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this
raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to
raise additional funds and is currently exploring alternative sources of financing. Historically, the Company raised capital through
private placements, to finance working capital needs and may attempt to raise capital through the sale of common stock or other
securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable.
Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends
to continue this practice where feasible.
Reverse
Stock Split
On
August 17, 2021, the Company initiated a 1 for 1,000 reverse split. Prior to the split, there were 130,200,000 shares outstanding.
After the split, there were 130,212 shares outstanding. The reverse split has been applied retroactively for all financial statements
presented unless specifically stated otherwise.
Use
of Estimates
The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income
taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other
assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements.
The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from these estimates.
Cash
and cash equivalents
The
Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents.
On December 31, 2021 and December 31, 2020, the Company’s cash equivalents totaled $-0- and $-0- respectively.
Income
taxes
The
Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740,
deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for
Uncertainty in Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement
recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized,
a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
The
amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate
settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts
or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability
under audit.
Net
Loss per Share
Net
loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as
defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”)
calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during
the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number
of common shares and dilutive common share equivalents outstanding.
Recent
Accounting Pronouncements
There
are no recent accounting pronouncements that impact the Company’s operations.
NOTE
3 - DEBT
As
of December 31, 2021, and December 31, 2020, the Company had $-0- and $-0- in debt outstanding, respectively.
NOTE
4 - RELATED PARTY DEBT
As of December 31, 2021 and December 31, 2020 the balance of notes payable due to related parties was $1,972 and $5,345, respectively. These notes payable were comprised of interest-free demand loans.
NOTE
5 - EQUITY
Common
Stock
Reverse
Stock Split
On
August 17, 2021, the Company initiated a 1 for 1,000 reverse split. Prior to the split, there were 130,200,000 shares outstanding.
After the split, there were 130,212 shares outstanding. The reverse split has been applied retroactively for all financial statements
presented unless specifically stated otherwise.
The
Company has authorized 300,000,000 shares of $0.001 par value, common stock. As of December 31, 2021 and December 31, 2020, there
were 130,212 and 130,212 shares of Common Stock issued and outstanding, respectively.
Preferred
Stock
On
September 24, 2020, the Company designated 10,000,000 shares of Preferred A stock, par value $0.0001, and awarded Custodian Ventures
these shares that carry 30 to 1 conversion rights into common shares. These shares were awarded in return for a reduction of $10,000
of related party loans extended by Custodian Ventures to the Company. As a result, the Company recorded stock-based compensation
of $2,450,000 related to these shares.
On
March 22, 2021, as a result of a private transaction, these 10,000,000 shares of Series A Preferred Stock, were transferred from
Custodian Ventures, LLC to Flowerkist Inc. (the “Purchaser”). As a result, the Purchaser became an approximately 70%
holder of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted basis of the Company
and became the controlling shareholder.
As
of December 31, 2021, and December 31, 2020, there were 10,000,000 and 10,000,000 shares of Series A outstanding, respectively.
NOTE
6 - COMMITMENTS AND CONTINGENCIES
The
Company did not have any contractual commitments as of December 31, 2021 and December 31, 2020.

---

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Item
9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure
None

---

ITEM 9A. CONTROLS AND PROCEDURES
Item
9A. Controls and Procedures
Disclosure
Controls and Procedures
We
conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness
of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended, or the Exchange Act, as of December 31, 2021, to ensure that information required to be disclosed
by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the
time periods specified in the Securities Exchange Commission’s rules and forms, including to ensure that information required
to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management,
including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to
allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial
Officer have concluded that as of December 31, 2021, our disclosure controls and procedures were not effective at the reasonable
assurance level due to the material weaknesses identified and described in Item 9A(b).
Our
principal executive officers do not expect that our disclosure controls or internal controls will prevent all error and all fraud.
Although our disclosure controls and procedures were designed to provide reasonable assurance of achieving their objectives and
our principal executive officers have determined that our disclosure controls and procedures are effective at doing so, a control
system, no matter how well conceived and operated, can provide only reasonable, not absolute assurance that the objectives of
the system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the
benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no
evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company
have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that
breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented if there exists in an individual
a desire to do so. There can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions.
Based
on the evaluation of our disclosure controls and procedures, management has concluded that our disclosure controls and procedures
were not effective as of the end of the period covered by this annual report at the reasonable assurance level.
Management
Report on Internal Control Over Financial Reporting
Our
management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control
over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act, as amended, as a
process designed by, or under the supervision of, our principal executive and principal financial officer and effected by our
board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles
in the United States and includes those policies and procedures that:
● Pertain to the maintenance
of records that in reasonable detail accurately and fairly reflect our transactions and any disposition of our assets;
● Provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations
of our management and directors; and
● Provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could
have a material effect on the financial statements.
Because
of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or
detected on a timely basis. Our management assessed the effectiveness of our internal control over financial reporting as of December
31, 2021. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of
the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on this assessment, Management identified
the following two material weaknesses that have caused management to conclude that, as of December 31, 2021, our disclosure controls
and procedures, and our internal control over financial reporting, were not effective at the reasonable assurance level:
1. We
do not have written documentation of our internal control policies and procedures. Written
documentation of key internal controls over financial reporting is a requirement of Section
404 of the Sarbanes-Oxley Act as of the year ending December 31, 2021. Management evaluated
the impact of our failure to have written documentation of our internal controls and
procedures on our assessment of our disclosure controls and procedures and has concluded
that the control deficiency that resulted represented a material weakness.
2. We
do not have sufficient segregation of duties within accounting functions, which is a
basic internal control. Due to our size and nature, segregation of all conflicting duties
may not always be possible and may not be economically feasible. However, to the extent
possible, the initiation of transactions, the custody of assets and the recording of
transactions should be performed by separate individuals. Management evaluated the impact
of our failure to have segregation of duties on our assessment of our disclosure controls
and procedures and has concluded that the control deficiency that resulted represented
a material weakness.
3. Effective
controls over the control environment were not maintained. Specifically, a formally adopted
written code of business conduct and ethics that governs our employees, officers, and
directors was not in place. Additionally, management has not developed and effectively
communicated to employees its accounting policies and procedures. This has resulted in
inconsistent practices. Further, our Board of Directors does not currently have any independent
members and no director qualifies as an audit committee financial expert as defined in
Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive
effect across the organization, management has determined that these circumstances constitute
a material weakness.
To
address these material weaknesses, management performed additional analyses and other procedures to ensure that the financial
statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows
for the periods presented. Accordingly, we believe that the financial statements included in this report fairly present, in all
material respects, our financial condition, results of operations and cash flows for the periods presented.
Remediation
of Material Weaknesses
To
remediate the material weakness in our documentation, evaluation, and testing of internal controls we plan to engage a third-party
firm to assist us in remedying this material weakness once resources become available.
We
intend to remedy our material weakness with regard to insufficient segregation of duties by hiring additional employees in order
to segregate duties in a manner that establishes effective internal controls once resources become available.
Changes
in Internal Control over Financial Reporting
No
change in our system of internal control over financial reporting occurred during the period covered by this report, the fiscal
year ended December 31, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control
over financial reporting.

---

ITEM 9B. OTHER INFORMATION
Item
9B. Other Information
None
PART
III

---

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Item
10. Directors, Executive Officers and Corporate Governance
The
following table contains information with respect to our current executive officer and director:
Name
Age
Principal
Positions With Us
Barry
Clark
President,
Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director
Barry
Clark, 62, is the co-founder of Flowerkist, Inc., along with Stephanie Clark and the Chairman of the Board of Directors, which
was founded in 2017. He also acts as a business mentor at CanopySD, a seed-stage mentorship-driven accelerator program for the
legal cannabis industry in Southern California. Mr. Clark was the founder and managing director of Sussex Partners Investor Relations
and Regal Barrington from 2004 through 2014.
Term
of Office
Our
directors are appointed for a one-year term to hold office until the next annual general meeting of our shareholders or until
removed from office in accordance with our bylaws. Our officers are appointed by our board of directors and hold office until
removed by the board.
Family
Relationships
There
are no family relationships between or among the directors, executive officers or persons nominated or chosen by us to become
directors or executive officers.
Involvement
in Certain Legal Proceedings
To
the best of our knowledge, during the past ten years, none of the following occurred with respect to a present or former director,
executive officer, or employee: (1) any bankruptcy petition filed by or against any business of which such person was a general
partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (2) any conviction in
a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
(3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent
jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type
of business, securities or banking activities; and (4) being found by a court of competent jurisdiction (in a civil action), the
SEC or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment
has not been reversed, suspended or vacated.
Committees
of the Board
Our
company currently does not have nominating, compensation or audit committees or committees performing similar functions nor does
our company have a written nominating, compensation, or audit committee charter. Our directors believe that it is not necessary
to have such committees, at this time, because the functions of such committees can be adequately performed by the board of directors.
Our
company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations
for directors. The board of directors believes that, given the stage of our development, a specific nominating policy would be
premature and of little assistance until our business operations develop to a more advanced level. Our company does not currently
have any specific or minimum criteria for the election of nominees to the board of directors and we do not have any specific process
or procedure for evaluating such nominees. The board of directors will assess all candidates, whether submitted by management
or shareholders, and make recommendations for election or appointment.
A
shareholder who wishes to communicate with our board of directors may do so by directing a written request addressed to our CEO
and director, Barry Clark at the address appearing on the first page of this annual report.
Code
of Ethics
We
have not adopted a Code of Ethics that applies our principal executive officer, principal financial officer, principal accounting
officer or controller, or persons performing similar functions.

---

ITEM 11. EXECUTIVE COMPENSATION
Item
11. Executive Compensation
Barry
Clark, the Company’s only Officer and Director received no compensation for his services.

---

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The
following table sets forth, as of December 31, 2021, certain information as to shares of our voting stock owned by (i) each person
known by us to beneficially own more than 5% of our outstanding voting stock, (ii) each of our directors, and (iii) all of our
executive officers and directors as a group.
Unless
otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their
shares of voting stock, except to the extent authority is shared by spouses under applicable law.
Name
and Address of Beneficial Owners of Common Stock
Title
of Class
Amount
and
Nature of
Beneficial
Ownership(1)
%
of
Common
Stock(2)
Flowerkist,
Inc.(4)
Preferred
Stock
10,000,000 (3)
99.9 %
DIRECTORS
AND OFFICERS - TOTAL
(Two Officers and Directors)
Preferred Stock
10,000,000
99.7 %
5%
SHAREHOLDERS
Market
Milestones, Inc.
Taylor L. Touchette
310 Cedar Lake Drive
League City, Texas 77573
Common Stock
72,600 Shares
55.8 %
Jason
Zeng
160 Frederick St. Ste. 906
Toronto, ON Canada M5A4H9
Common Stock
26,000 Shares
20.0 %
(1) Beneficial
Ownership is determined in accordance with the rules of the SEC and generally includes
voting or investment power with respect to securities. Shares of common stock subject
to options or warrants currently exercisable or convertible, or exercisable or convertible
within 60 days of March 31, 2022 are deemed outstanding for computing the percentage
of the person holding such option or warrant but are not deemed outstanding for computing
the percentage of any other person.
(2) Based
upon 130,200 shares issued and outstanding on December 31, 2021, and including the if
converted common shares.
(3) The
preferred is convertible to common at the rate of 30 to 1, or 300,000,000 common shares.
(4) Barry
Clark, the CEO, and Stephanie Parker, President of Flowerkist have voting and dispositive
power of these shares.

---

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Item
13. Certain Relationships and Related Transactions, and Director Independence
As
of the date of this Report, Flowerkist Inc. had extended $-0- in interest free demand loans to the Company.

---

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Item
14. Principal Accounting Fees and Services
Audit Fees: Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and services that are normally provided in connection with statutory and regulatory filings. Fees incurred were $21,500 and $5,400 for the years ended December 31, 2021 and December 31, 2020.
Audit-Related
Fees: Audit-related services consist of fees billed for assurance and related services that are reasonably related to the performance
of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include
attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting
standards and were not incurred for the years ended December 31, 2021 and December 31, 2020.
Tax
Services Fees: Tax fees consist of fees billed for professional services for tax compliance. These services include assistance
regarding federal, state, and local tax compliance. Tax fees were not incurred during the fiscal year ended December 31, 2021.
All
Other Fees: Other fees, which were not incurred, would include fees for products and services other than the services reported
above.
PART
IV

---

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Item
15. Exhibits, Financial Statements Schedules
(a) Financial Statements
and Schedules
The
following financial statements and schedules listed below are included in this Form 10-K.
Financial
Statements (See Item 8)
(b) Exhibits
Exhibit
Number
Description
31.1
Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2
Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Flowerkist
Skin Care and Cosmetics, Inc.
Date: April 15, 2022
By: /s/ Barry
Clark
Barry
Clark
Title: Chief
Executive Officer and Director
By: /s/ Stephanie Parker
Stephanie Parker
Title: President and Director